13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 88 holding rows worth $4,538,793,244.
- Accession
- 0000950159-23-000305
- Filer
- CIK 1009258
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 88 entries on the cover page, a total value of $4,538,793,244 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,538,793,245 with VALUE read as dollars as filed, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUVALENT INC COM | 670703107 | Stock | 19,991,024 | $918,987,373 | dollars as filed | |
| GLAUKOS CORP | 377322AB8 | BOND | 271,452,000 | $426,548,000 | dollars as filed | principal |
| VIATRIS INC COM | 92556V106 | Stock | 19,863,485 | $195,853,962 | dollars as filed | |
| Invitae Corporation | 46185LAH6 | Series A Notes 4.5% 3/15/2028 | 217,766,000 | $163,823,402 | dollars as filed | principal |
| TABULA RASA HEALTHCARE INC | 873379AA9 | NOTE | 144,516,000 | $141,534,635 | dollars as filed | principal |
| CENTENE CORP DEL COM | 15135B101 | Stock | 1,990,000 | $137,071,200 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,209,714 | $136,092,825 | dollars as filed | |
| NATERA INC | 632307AB0 | BOND | 101,042,000 | $133,525,487 | dollars as filed | principal |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 13,607,940 | $123,832,254 | dollars as filed | |
| BROOKDALE SR LIVING INC | 112463AC8 | NOTE 2.000%10/1 | 145,955,000 | $114,346,109 | dollars as filed | principal |
| ACCOLADE INC | 00437EAB8 | NOTE 0.500% 4/0 | 132,598,000 | $107,928,275 | dollars as filed | principal |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 108,858,000 | $107,555,623 | dollars as filed | principal |
| INTERCEPT PHARMACEUTICALS IN | 45845PAC2 | NOTE 3.500% 2/1 | 98,354,000 | $105,134,820 | dollars as filed | principal |
| ACCENDRA HEALTH INC | 690732102 | COM | 6,435,000 | $103,989,600 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 8,192,000 | $95,764,480 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 3,876,938 | $91,418,198 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 6,897,606 | $87,737,548 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 16,941,357 | $66,918,360 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 173,947 | $62,351,302 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,268,628 | $61,207,583 | dollars as filed | |
| ENHABIT INC | 29332G102 | COM | 4,997,746 | $56,224,643 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 4,004,231 | $53,856,907 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 70,204,000 | $53,000,791 | dollars as filed | principal |
| BROOKDALE SR LIVING INC | 112463104 | COM | 12,679,651 | $52,493,755 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,751,496 | $48,481,409 | dollars as filed | |
| LIVONGO HEALTH INC | 539183AA1 | NOTE 0.875% 6/0 | 50,000,000 | $45,665,200 | dollars as filed | principal |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 1,126,827 | $43,033,523 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 1,460,000 | $42,705,000 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 11,077,927 | $41,874,564 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 4,374,044 | $39,891,281 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 1,329,935 | $39,419,273 | dollars as filed | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 2,077,893 | $38,524,136 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 1,579,574 | $36,519,751 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 2,340,118 | $35,616,596 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 15,873,213 | $33,651,212 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 627,813 | $31,654,331 | dollars as filed | |
| HEALTH CATALYST INC | 42225TAB3 | BOND | 30,000,000 | $28,517,130 | dollars as filed | principal |
| RAYZEBIO INC | 75525N107 | COM | 1,159,126 | $25,732,597 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 4,764,000 | $25,392,120 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 3,286,000 | $23,264,880 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,933,137 | $22,536,875 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 127,000 | $20,255,230 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 430,000 | $20,201,400 | dollars as filed | |
| ALIGNMENT HEALTHCARE INC COM | 01625V104 | Stock | 2,747,015 | $19,064,284 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,604,487 | $18,740,408 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366JAD3 | NOTE 1.500% 9/1 | 22,000,000 | $17,509,030 | dollars as filed | principal |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 3,500,000 | $16,730,000 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 946,620 | $15,988,412 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,269,992 | $15,582,802 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,279,000 | $14,158,530 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 754,042 | $13,399,326 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,538,461 | $12,507,688 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 594,989 | $12,274,623 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 150,000 | $10,956,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,089,345 | $10,621,114 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 1,017,958 | $10,515,506 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 870,000 | $9,978,900 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 1,827,400 | $9,849,686 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 448,753 | $9,015,448 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 793,729 | $8,937,389 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 885,314 | $8,445,896 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 650,000 | $8,274,500 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 723,000 | $7,916,850 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 2,823,000 | $7,339,800 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,055,192 | $6,837,644 | dollars as filed | |
| NEOGENOMICS INC | 64049MAA8 | Convertible Debt | 6,500,000 | $5,994,495 | dollars as filed | principal |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 3,360,052 | $4,704,073 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 1,253,895 | $4,564,178 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 777,525 | $3,887,625 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 400,256 | $2,821,805 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 930,447 | $2,670,383 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P200 | ADR | 316,169 | $2,443,986 | dollars as filed | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 4,984,871 | $1,899,236 | dollars as filed | |
| ACUTUS MED INC | 005111109 | COM | 2,660,808 | $1,853,519 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 583,913 | $1,378,035 | dollars as filed | |
| CUTERA INC | 232109108 | COM | 154,406 | $929,524 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 92,787 | $176,295 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 672,000 | $134,400 | dollars as filed | |
| Trisalus Life Sciences Inc W Exp 08/10/202 | 89680M119 | SPAC Combination | 333,333 | $126,667 | dollars as filed | |
| The Oncology Institute Inc W Exp 99/99/999 | 68236X118 | SPAC Combination | 1,250,000 | $114,875 | dollars as filed | |
| MEDAVAIL HOLDINGS INC COM NEW | 58406B202 | NEW | 16,732 | $100,392 | dollars as filed | |
| QUANTUM SI INC | 74765K113 | *W EXP 06/10/202 | 333,333 | $90,000 | dollars as filed | |
| BUTTERFLY NETWORK INC | 124155110 | *W EXP 02/12/202 | 733,333 | $48,547 | dollars as filed | |
| SIENTRA INC | 82621J204 | COMMON | 10,000 | $27,800 | dollars as filed | |
| SOMALOGIC INC | 83444k113 | WT | 120,000 | $26,412 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 166,666 | $16,667 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $6,850 | dollars as filed | |
| TRISALUS LIFE SCIENCES INC | 89680M101 | COM | 1 | $5 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950159-23-000305 | this filing | 2023-11-14 | acceptance time not in the bulk data set |